Febuxostat and tumor lysis syndrome: an indication that remains unclear
Int J Clin Oncol
.
2017 Jun;22(3):605-606.
doi: 10.1007/s10147-016-1070-1.
Epub 2016 Dec 1.
Authors
F Vincent
1
,
A Dupré
2
,
C Mousseaux
2
,
C Bornstain
2
,
M Darmon
3
4
5
Affiliations
1
Medical-Surgical Intensive Care Unit, Le Raincy-Montfermeil Hospital, 10 avenue du Général Leclerc, 93370, Montfermeil, France. frncsvncnt@aol.com.
2
Medical-Surgical Intensive Care Unit, Le Raincy-Montfermeil Hospital, 10 avenue du Général Leclerc, 93370, Montfermeil, France.
3
Medical-Surgical Intensive Care Unit, Saint-Etienne University Hospital, Saint-Etienne, France.
4
Jean Monnet Medical School, Saint-Etienne University, Saint-Etienne, France.
5
Thrombosis Research Group, EA 3065, Saint-Etienne University Hospital and Saint-Etienne Medical School, Saint-Etienne, France.
PMID:
27909836
DOI:
10.1007/s10147-016-1070-1
No abstract available
Publication types
Letter